You are using an older browser version. Please use a supported version for the best MSN experience.

5 Blockbuster M&A Deals of 2019

It's starting to feel a little like "Let's Make a Deal." Your Twitter feed no doubt blew up this morning when AbbVie agreed to pay for struggling Botox maker Allergan . Wall Street voices skepticism on AbbVie's $ABBV aggressive Allergan $AGN acquisition - @KevinCurranRM https://t.co/ZKweBGuVaO — Real Money (@realmoney) June 25, 2019 The price tag? The takeover bid comes in at a cool $63 billion. Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015. Read Real Money's take here. It's just the latest in a long string of deals for 2019. Watch the video for an M&A round-up. Related. Another Day, Another Deal: What to Watch from AbbVie, Allergan, Micron, Buffett Shares of Botox Maker Allergan Get a Lift

More From The Street

Recent Videos

Featured Partners

image beaconimage beaconimage beacon